5-Bromo-2-cyclopropylpyrimidine, 95.0%, 1g

(4R,12aS)-N-(2,4-Difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide, 97%, 10g

4-Amino-N,N-dimethylpiperidine-1-carboxamide hydrochloride, 95.0%, 1g

3-(2-Chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine, 95.0%, 5g

Diethyl cyclopentane-1,1-dicarboxylate, 95.0%, 5g

4-Piperidinecarboxamide, 4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, 98%, 25mg

2-Methoxy-benzamidine hydrochloride, 95.0%, 10g

3-Oxo-3,4-dihydro-2H-1,4-benzoxazine-6-carboxylic acid, 97.0%, 5g

Plats de cristallisation ROTILABO® avec bec verseur, 20 ml, 40 mm, 10 Pièce(s)

Feuille de vanadium 99,9+% 0,025 x 50 x 50 mm 1 pièce

2,2,5,5-Tetrakis(hydroxymethyl)cyclopentan-1-one, 98%, 250mg

(3R,4R,5R)-6-(((2S,3R,4S,5S,6R)-3,4,5-Trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexane-1,2,3,4,5-pentaol, 97.0%, 10g

2-Amino-3-fluoroisonicotinic acid, 97.0%, 250mg